Chemotherapy for Penile and Urethral Carcinoma

Urologic Clinics of North America

Volumn 37, Issue 3, 2010, Pages 467-474

  Trabulsi, E J ^a   Hoffman Censits, Jean ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Chemotherapy; Penile carcinoma; Urethral carcinoma

Indexed keywords

BLEOMYCIN; CARBOPLATIN; CETUXIMAB; CISPLATIN; DOCETAXEL; ERLOTINIB; FLUOROURACIL; FOLINIC ACID; GEMCITABINE; IFOSFAMIDE; IRINOTECAN; METHOTREXATE; PACLITAXEL; VINCRISTINE;

ANEMIA; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CELLULITIS; CLINICAL TRIAL; CREATININE CLEARANCE; CYTOPENIA; DIARRHEA; DRUG EFFICACY; DRUG FATALITY; DRUG MEGADOSE; DRUG SUBSTITUTION; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEBRILE NEUTROPENIA; GASTROINTESTINAL TOXICITY; GRANULOCYTOPENIA; HEART INFARCTION; HISTOPATHOLOGY; HUMAN; INFECTION; KIDNEY FAILURE; LOW DRUG DOSE; LUNG EMBOLISM; LUNG FIBROSIS; LUNG TOXICITY; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MUCOSA INFLAMMATION; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; NAUSEA AND VOMITING; NEUTROPENIA; PENIS CARCINOMA; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; SQUAMOUS CELL CARCINOMA; THROMBOCYTOPENIA; TINNITUS; TUMOR BLEEDING; URETHRA CARCINOMA;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; HUMANS; MALE; NEOADJUVANT THERAPY; PENILE NEOPLASMS; TAXOIDS; URETHRAL NEOPLASMS;

EID: 77955257288     PISSN: 00940143     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ucl.2010.04.010     Document Type: Review

References (34)

1. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2009. CA Cancer J Clin 2009, 59:225.
2. Horenblas S., Van Tinteren H., Delemarre J.F., et al. Squamous cell carcinoma of the penis: accuracy of tumor, nodes and metastasis classification system, and role of lymphangiography, computerized tomography scan and fine needle aspiration cytology. J Urol 1991, 146:1279.
3. Ornellas A.A., Seixas A.L., Marota A., et al. Surgical treatment of invasive squamous cell carcinoma of the penis: retrospective analysis of 350 cases. J Urol 1994, 151:1244.
4. Leijte J.A., Kerst J.M., Bais E., et al. Neoadjuvant chemotherapy in advanced penile carcinoma. Eur Urol 2007, 52:488.
5. Pizzocaro G., Piva L. Adjuvant and neoadjuvant vincristine, bleomycin, and methotrexate for inguinal metastases from squamous cell carcinoma of the penis. Acta Oncol 1988, 27:823.
6. Bermejo C., Busby J.E., Spiess P.E., et al. Neoadjuvant chemotherapy followed by aggressive surgical consolidation for metastatic penile squamous cell carcinoma. J Urol 2007, 177:1335.
7. Haas G.P., Blumenstein B.A., Gagliano R.G., et al. Cisplatin, methotrexate and bleomycin for the treatment of carcinoma of the penis: a Southwest Oncology Group study. J Urol 1999, 161:1823.
8. Gagliano R.G., Blumenstein B.A., Crawford E.D., et al. cis-Diamminedichloroplatinum in the treatment of advanced epidermoid carcinoma of the penis: a Southwest Oncology Group Study. J Urol 1989, 141:66.
9. Pizzocaro G., Nicolai N., Milani A. Taxanes in combination with cisplatin and fluorouracil for advanced penile cancer: preliminary results. Eur Urol 2009, 55:546.
10. Culkin D.J., Beer T.M. Advanced penile carcinoma. J Urol 2003, 170:359.
11. Pizzocaro G., Algaba F., Horenblas S., et al. EAU Penile Cancer Guidelines 2009. Eur Urol 2000, [Epub ahead of print]. PMID: 20163910.
12. Pizzocaro G., Piva L., Bandieramonte G., et al. Up-to-date management of carcinoma of the penis. Eur Urol 1997, 32:5.
13. Ravi R. Correlation between the extent of nodal involvement and survival following groin dissection for carcinoma of the penis. Br J Urol 1993, 72:817.
14. Hakenberg O.W., Nippgen J.B., Froehner M., et al. Cisplatin, methotrexate and bleomycin for treating advanced penile carcinoma. BJU Int 2006, 98:1225.
15. Ichikawa T., Nakano I., Hirokawa I. Bleomycin treatment of the tumors of penis and scrotum. J Urol 1969, 102:699.
16. Maiche A.G. Adjuvant treatment using bleomycin in squamous cell carcinoma of penis: study of 19 cases. Br J Urol 1983, 55:542.
17. Sklaroff R.B., Yagoda A. Cis-diamminedichloride platinum II (DDP) in the treatment of penile carcinoma. Cancer 1979, 44:1563.
18. Garnick M.B., Skarin A.T., Steele G.D. Metastatic carcinoma of the penis: complete remission after high dose methotrexate chemotherapy. J Urol 1979, 122:265.
19. Sklaroff R.B., Yagoda A. Methotrexate in the treatment of penile carcinoma. Cancer 1980, 45:214.
20. Ahmed T., Sklaroff R., Yagoda A. Sequential trials of methotrexate, cisplatin and bleomycin for penile cancer. J Urol 1984, 132:465.
21. Hussein A.M., Benedetto P., Sridhar K.S. Chemotherapy with cisplatin and 5-fluorouracil for penile and urethral squamous cell carcinomas. Cancer 1990, 65:433.
22. Shammas F.V., Ous S., Fossa S.D. Cisplatin and 5-fluorouracil in advanced cancer of the penis. J Urol 1992, 147:630.
23. Dexeus F.H., Logothetis C.J., Sella A., et al. Combination chemotherapy with methotrexate, bleomycin and cisplatin for advanced squamous cell carcinoma of the male genital tract. J Urol 1991, 146:1284.
24. Theodore C., Skoneczna I., Bodrogi I., et al. A phase II multicentre study of irinotecan (CPT 11) in combination with cisplatin (CDDP) in metastatic or locally advanced penile carcinoma (EORTC PROTOCOL 30992). Ann Oncol 2008, 19:1304.
25. Power D.G., Galvin D.J., Cuffe S., et al. Cisplatin and gemcitabine in the management of metastatic penile cancer. Urol Oncol 2009, 27:187.
26. Joerger M., Warzinek T., Klaeser B., et al. Major tumor regression after paclitaxel and carboplatin polychemotherapy in a patient with advanced penile cancer. Urology 2004, 63:778.
27. Di Lorenzo G., Carteni G., Autorino R., et al. Activity and toxicity of paclitaxel in pretreated metastatic penile cancer patients. Anticancer Drugs 2009, 20:277.
28. Nicolai N, Necchi A, Piva L, et al. A combination of cisplatin and 5-fluorouracil plus a taxane for advanced squamous-cell carcinoma (SCC) of the penis: a single-institution series [abstract #255]. In: American Society of Clinical Oncology Genitourinary Cancers Symposium, San Francisco (CA), March 5-7, 2010.
29. Bonner J.A., Harari P.M., Giralt J., et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 2006, 354:567.
30. Carthon BC, Pettaway CA, Pagliaro LC. Epidermal growth factor receptor (EGFR) targeted therapy in advanced metastatic squamous cell carcinoma (AMSCC) of the penis [abstract #254]. In: American Society of Clinical Oncology Genitourinary Cancers Symposium, San Francisco (CA), March 5-7, 2010.
31. Bonner J.A., Harari P.M., Giralt J., et al. Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival. Lancet Oncol 2010, 11:21.
32. Jonker D.J., O'Callaghan C.J., Karapetis C.S., et al. Cetuximab for the treatment of colorectal cancer. N Engl J Med 2007, 357:2040.
33. Kawano K., Yano M., Kitahara S., et al. Clear cell adenocarcinoma of the female urethra showing strong immunostaining for prostate-specific antigen. BJU Int 2001, 87:412.
34. Seballos R.M., Rich R.R. Clear cell adenocarcinoma arising from a urethral diverticulum. J Urol 1995, 153:1914.